TerrAscend (OTCMKTS:TSNDF – Get Free Report) and Varex Imaging (NASDAQ:VREX – Get Free Report) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, dividends, institutional ownership, analyst recommendations, risk and profitability.
Profitability
This table compares TerrAscend and Varex Imaging’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| TerrAscend | -28.96% | -30.76% | -4.89% |
| Varex Imaging | 2.55% | 9.19% | 4.13% |
Volatility and Risk
TerrAscend has a beta of 1.47, suggesting that its share price is 47% more volatile than the S&P 500. Comparatively, Varex Imaging has a beta of 1.02, suggesting that its share price is 2% more volatile than the S&P 500.
Analyst Recommendations
This is a summary of current ratings and target prices for TerrAscend and Varex Imaging, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| TerrAscend | 0 | 1 | 0 | 0 | 2.00 |
| Varex Imaging | 0 | 7 | 0 | 0 | 2.00 |
Varex Imaging has a consensus target price of $16.88, suggesting a potential downside of 6.92%. Given Varex Imaging’s higher possible upside, analysts clearly believe Varex Imaging is more favorable than TerrAscend.
Institutional & Insider Ownership
5.8% of TerrAscend shares are held by institutional investors. 31.9% of TerrAscend shares are held by insiders. Comparatively, 4.6% of Varex Imaging shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Earnings & Valuation
This table compares TerrAscend and Varex Imaging”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| TerrAscend | $260.56 million | 0.46 | -$81.33 million | ($0.09) | -4.31 |
| Varex Imaging | $865.00 million | 0.89 | -$70.30 million | $0.52 | 34.87 |
Varex Imaging has higher revenue and earnings than TerrAscend. TerrAscend is trading at a lower price-to-earnings ratio than Varex Imaging, indicating that it is currently the more affordable of the two stocks.
Summary
Varex Imaging beats TerrAscend on 9 of the 12 factors compared between the two stocks.
About TerrAscend
TerrAscend is a cannabis company that cultivates, processes and sells cannabis products through retail and wholesale channels. Its offerings include cannabis flower, pre-rolls, concentrates, edibles and other consumer products, sold under a portfolio of company and partner brands. The company operates in several U.S. markets, including Pennsylvania, New Jersey, Maryland, Michigan and California. Its retail business includes dispensaries operating under names such as The Apothecarium and Gage, alongside cultivation and processing facilities that supply its stores and other retailers.
About Varex Imaging
Varex Imaging Corporation designs and manufactures components used in X-ray imaging systems. Its products include X-ray tubes, digital detectors, image-processing solutions and related software and services for medical and industrial applications. In healthcare, Varex’s components are used in systems for applications such as radiography, computed tomography, mammography and oncology. Its industrial products support inspection and analysis in areas including security screening and nondestructive testing.
Receive News & Ratings for TerrAscend Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TerrAscend and related companies with MarketBeat.com's FREE daily email newsletter.
